Educational Webinars

Phase 2a trial of Oral LAM-002A capsules in C9ORF72 ALS


Please join us on February 24th for a webinar to learn about a new Phase 2a trial of Oral LAM-002A capsules for individuals with C9ORF72 positive ALS.